Status:
COMPLETED
A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye
Lead Sponsor:
Innovative Medical
Conditions:
Dry Eye
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To evaluate the effectiveness of NGT (Optive) vs. Systane Tears for patients with moderate to severe dry eye disease.
Eligibility Criteria
Inclusion
- · Dry eye disease diagnosis
- Patients must currently be using Systane tears at least once a day and for at least 1 month.
- Normal lid position and closure
- Male or female of legal age of consent
- Informed consent has been obtained
- Likely to complete all required follow-up visits
Exclusion
- · Concurrent enrollment in an investigational drug or device study, or participation in such a study within 30 days of entry into this study.
- Subject has a condition, or is in a situation which, in the investigator's opinion, may put the subject at a significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00399230
Last Update
August 21 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Rajpal
McLean, Virginia, United States, 22102